Drug was developed by British pharmaceutical giant Astra Zeneca with the aim of treating certain types of tumour, but was shelved after it proved ineffective .
Scientists at Yale University in the US have revealed how the treatment, called AZDO503030, restored memory in mice given Alzheimer's .
It worked by blocking a process that breaks nerve connections in the brain used to store memory .
The study has led to the launch of human trials to test the drug in Alzheimer's patients .